Table 2.
Baseline lesion characteristics
| BP-EES (n = 12) | BVS (n = 12) | P value | |
|---|---|---|---|
| Number of lesions | 13 | 17 | |
| Target vessel, n (%) | |||
| LAD | 3 (25.0) | 5 (41.7) | 0.102 |
| LCX | 8 (66.7) | 3 (25.0) | |
| RCA | 1 (8.3) | 4 (33.3) | |
| Bifurcation, n (%) | 9 (75.0) | 3 (25.0) | 0.039 |
| Eccentric, n (%) | 9 (75.0) | 4 (33.3) | 0.095 |
| Bend (degree) | 23.3 ± 15.7 | 32.5 ± 20.7 | 0.236 |
| Type B2/C lesions, n (%) | 12 (100) | 10 (83.3) | 0.478 |
| RVD (mm) | 2.60 ± 0.57 | 2.69 ± 0.30 | 0.639 |
| MLD (mm) | 0.95 ± 0.53 | 1.02 ± 0.35 | 0.695 |
| DS (%) | 65.3 ± 13.0 | 62.0 ± 13.2 | 0.541 |
| Lesion length (mm) | 33.7 ± 7.3 | 35.4 ± 15.9 | 0.737 |
Data are presented as mean ± SD or number (%)
BP-EES bioresorbable polymer-coated everolimus-eluting stents, BVS bioresorbable vascular scaffolds, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery, RVD reference vessel diameter, MLD minimal lumen diameter, DS diameter stenosis